MedPath

ANTIGEN LABORATORIES INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

44

FDA:44

Drug Approvals

Treatment Set TS345463

Approval Date
May 11, 2012
FDA

Treatment Set TS344592

Approval Date
Mar 23, 2012
FDA

Treatment Set TS344558

Approval Date
Jan 18, 2012
FDA

Treatment Set TS344059

Approval Date
Dec 29, 2011
FDA

Treatment Set TS343825

Approval Date
Nov 22, 2011
FDA

Treatment Set TS342922

Approval Date
Sep 28, 2011
FDA

Treatment Set TS340987

Approval Date
Jun 8, 2011
FDA

Treatment Set TS340796

Approval Date
Mar 30, 2011
FDA

Treatment Set TS339754

Approval Date
Mar 15, 2011
FDA

Treatment Set TS340074

Approval Date
Mar 14, 2011
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Phase 2 Study in Adults Sensitized to Cat

Phase 2
Completed
Conditions
Allergy
First Posted Date
2008-06-03
Last Posted Date
2014-05-01
Lead Sponsor
Antigen Laboratories, Inc.
Target Recruit Count
167
Registration Number
NCT00689299
Locations
🇺🇸

Allergy & Asthma Medical Group & Research Center, San Diego, California, United States

🇺🇸

Allergen Response and Research Center, Marietta, Georgia, United States

🇺🇸

Clinical Research Center, St. Louis, Missouri, United States

Phase 2 Study in Adults Sensitized to Short Ragweed

Phase 2
Withdrawn
Conditions
Allergic Rhinitis
First Posted Date
2008-05-01
Last Posted Date
2014-01-09
Lead Sponsor
Antigen Laboratories, Inc.
Registration Number
NCT00670384

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.